Mo, Y. et al. 2023. Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. Radiology and Oncology. 57, 3 (Sep. 2023), 405–410.